Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.010 Biomarker group BEFREE Thus, Twist1 in the distal nephron rather than in infiltrating macrophages propagates chronic inflammation and fibrogenesis during aristolochic acid-induced nephropathy. 31685313 2020
CUI: C0205944
Disease: Sarcoma, Epithelioid
Sarcoma, Epithelioid
0.010 AlteredExpression disease BEFREE Notably, high levels of miR-186 and low levels of TWIST1 correlate with better prognosis in ES patients. 31639426 2020
Hereditary lymphedema and yellow nails
0.010 Biomarker disease BEFREE Lymphatic dysfunction is hypothesized to be an underlying factor in the pathophysiology of yellow nail syndrome (YNS) (yellow nails, lymphedema, pleural effusions, and frequently chronic rhinosinusitis [CRS]). 31589812 2020
CUI: C0238003
Disease: Adenocarcinoma of appendix
Adenocarcinoma of appendix
0.010 Biomarker disease BEFREE Of 514 patients undergoing CRS-HIPEC for appendiceal adenocarcinoma, 125 (24%) had SCA. 31428960 2020
CUI: C4049993
Disease: Aristolochic Acid Nephropathy
Aristolochic Acid Nephropathy
0.010 AlteredExpression disease BEFREE The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy. 31685313 2020
CUI: C0001956
Disease: Alcohol Use Disorder
Alcohol Use Disorder
0.010 Biomarker disease BEFREE Secondary outcomes measures were Patient Health Questionnaire-9 (PHQ-9), The Generalized Anxiety Disorder 7-item scale (GAD-7), The Relation Assessment Scale Generic (RAS-G), The Alcohol Use Disorders Identification Test (AUDIT), The Inventory of Consequences of Gambling for the Gambler and CSO (ICS), and adherence to treatment for both the problem gambler and the CSO. 31746075 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE We revealed that GATA4-Twist1-Snail signalling triggers EC dysfunction and atherosclerosis; this work could lead to the development of novel anti-atherosclerosis therapeutics. 30809744 2019
CUI: C0004114
Disease: Astrocytoma
Astrocytoma
0.010 Biomarker disease BEFREE Twist1 promotes the formation of VM and the development of astrocytomas, and may also regulate the formation of VM via vascular endothelial-cadherin and matrix metalloproteinase-9. 31289562 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE We revealed that GATA4-Twist1-Snail signalling triggers EC dysfunction and atherosclerosis; this work could lead to the development of novel anti-atherosclerosis therapeutics. 30809744 2019
CUI: C0005697
Disease: Neurogenic Urinary Bladder
Neurogenic Urinary Bladder
0.010 Biomarker disease BEFREE A Retrospective Case Series of High-Frequency Spinal Cord Stimulation (HF10-SCS) in Neurogenic Bladder Incontinence. 30169840 2019
CUI: C0007130
Disease: Mucinous Adenocarcinoma
Mucinous Adenocarcinoma
0.010 Biomarker disease BEFREE Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin. 31109821 2019
CUI: C0007766
Disease: Intracranial Aneurysm
Intracranial Aneurysm
0.010 GeneticVariation disease BEFREE A genetic variant at rs10230207, located nearby the HDAC9, TWIST1, and FERD3L genes, is associated with IA. 30919159 2019
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.010 Biomarker group BEFREE Our analysis, with all the limitations related to included studies, suggests that peritoneal metastasis of rectal tumors treated with CRS and HIPEC have a worst prognosis of colon tumors PM. 31217079 2019
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.010 Biomarker disease BEFREE Using design-based stereology, we have measured the effects of a stress-induced depression model (chronic restraint stress, CRS) and ECS on the morphology of the hippocampus by estimating the volume and total number of neurons in the hilus, CA1, and CA2/3, as well as in the entire hippocampus. 30656862 2019
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.010 Biomarker disease BEFREE Using design-based stereology, we have measured the effects of a stress-induced depression model (chronic restraint stress, CRS) and ECS on the morphology of the hippocampus by estimating the volume and total number of neurons in the hilus, CA1, and CA2/3, as well as in the entire hippocampus. 30656862 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.010 AlteredExpression disease BEFREE However, whether PIO attenuates renal fibrosis and delays diabetic nephropathy progression by regulating Twist-1 expression remains unclear. 31506251 2019
CUI: C0015967
Disease: Fever
Fever
0.010 Biomarker phenotype BEFREE We aim to evaluate the knowledge, attitudes, and practice of surgeons regarding their nutritional support for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS and HIPEC) via a survey directed to self-evaluate nutritional knowledge, screening, and practice toward patients. 30298962 2019
CUI: C0018681
Disease: Headache
Headache
0.010 Biomarker phenotype BEFREE A recent expert clinical consensus statement also concluded that BSD is not appropriate for treatment of patients with headache that do not meet the diagnostic criteria for CRS or RARS or patients who do not have both positive findings of sinus disease on computed tomography and sinonasal symptoms. 30507684 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.010 Biomarker phenotype BEFREE However, for SCS, the total number of parameters indicating hyperalgesia was significantly reduced in the ON-condition (45 vs. 23, P=0.001). 30260842 2019
CUI: C0021167
Disease: Incontinence
Incontinence
0.010 Biomarker disease BEFREE To evaluate the efficacy of HF-SCS at 10 kHz in alleviating lower urinary tract dysfunction and bladder incontinence in 5 patients with underlying neurological disease or spinal cord injury, through retrospective study. 30169840 2019
CUI: C0022578
Disease: Keratoconus
Keratoconus
0.010 Biomarker disease BEFREE To evaluate intra-subject repeatability of anterior segment optical coherence tomography (AS-OCT) combined with placido disc MS-39 (CSO, Firenze, Italy) and correlate epithelial thickness measurements and the degree of visual limitation in keratoconus patients. 30689987 2019
CUI: C0023222
Disease: Pain in lower limb
Pain in lower limb
0.010 GeneticVariation phenotype BEFREE Patient-reported back and leg pain using the visual analog scale (VAS) and opioid dose (milligrams morphine equivalent/day, MME/day) were compared at 12 months post-10 kHz SCS therapy to baseline. 31391503 2019
CUI: C0023487
Disease: Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
0.010 Biomarker disease BEFREE On the basis of a detailed functional screen of synthetic peptides, we discovered a peptide analogous to the TWIST1 WR domain that specifically represses APL cell survival by disrupting the TRIB3/TWIST1 interaction. 31235507 2019
CUI: C0023646
Disease: Lichen Planus
Lichen Planus
0.010 Biomarker disease BEFREE The number of TWIST1-expressing cells in the stroma was higher in lichen planus than in controls (P < 0.001). 31228209 2019
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.010 AlteredExpression disease BEFREE Additionally, mechanistic studies further demonstrated that AEBP1 promoted COAD cell proliferation, migration, and invasion by upregulating the expression of matrix metalloproteinase-2, vimentin, and TWIST whereas downregulating that of E-cadherin through the nuclear factor-κB pathway. 31219650 2019